Search research articles
Contact Us
Filters
Showing results (1-10 of 77) with videos related to
Page
of 8
Sort By:
Biochimica Et Biophysica Acta. Molecular Cell Research
|
July 22, 2018
Physiologic functions of PP2A: Lessons from genetically modified mice
Sara Reynhout, Veerle Janssens
The International Journal of Biochemistry & Cell Biology
|
October 17, 2017
Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification
Bob Meeusen, Veerle Janssens
Frontiers in Oncology
|
June 20, 2019
PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Michiel Remmerie, Veerle Janssens
Oncoscience
|
January 19, 2018
<i>In vivo</i> pieces of the PP2A onco-puzzle fallen into place
Bob Meeusen, Veerle Janssens
The FEBS Journal
|
February 4, 2012
PP1 and PP2A phosphatases--cooperating partners in modulating retinoblastoma protein activation
Victoria Kolupaeva, Veerle Janssens
International Journal of Molecular Sciences
|
August 15, 2018
Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
Michiel Remmerie, Veerle Janssens
Frontiers in Cell and Developmental Biology
|
October 31, 2022
The role of serine/threonine phosphatases in human development: Evidence from congenital disorders
Pieter Vaneynde, Iris Verbinnen, Veerle Janssens
Aging
|
November 11, 2023
PME-1-regulated neural cell death: new therapeutic opportunities?
Liesbeth Guffens, Rita Derua, Veerle Janssens
Trends in Biochemical Sciences
|
February 23, 2008
PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail)
Veerle Janssens, Sari Longin, Jozef Goris
Cell Death Discovery
|
July 27, 2023
PME-1 sensitizes glioblastoma cells to oxidative stress-induced cell death by attenuating PP2A-B55α-mediated inactivation of MAPKAPK2-RIPK1 signaling
Liesbeth Guffens, Rita Derua, Veerle Janssens
Page
of 8
Search research articles
Search
Showing results (1-10 of 77) with videos related to
Sort By:
Page
of 8
Biochimica Et Biophysica Acta. Molecular Cell Research
|
July 22, 2018
Physiologic functions of PP2A: Lessons from genetically modified mice
Sara Reynhout, Veerle Janssens
The International Journal of Biochemistry & Cell Biology
|
October 17, 2017
Tumor suppressive protein phosphatases in human cancer: Emerging targets for therapeutic intervention and tumor stratification
Bob Meeusen, Veerle Janssens
Frontiers in Oncology
|
June 20, 2019
PP2A: A Promising Biomarker and Therapeutic Target in Endometrial Cancer
Michiel Remmerie, Veerle Janssens
Oncoscience
|
January 19, 2018
<i>In vivo</i> pieces of the PP2A onco-puzzle fallen into place
Bob Meeusen, Veerle Janssens
The FEBS Journal
|
February 4, 2012
PP1 and PP2A phosphatases--cooperating partners in modulating retinoblastoma protein activation
Victoria Kolupaeva, Veerle Janssens
International Journal of Molecular Sciences
|
August 15, 2018
Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
Michiel Remmerie, Veerle Janssens
Frontiers in Cell and Developmental Biology
|
October 31, 2022
The role of serine/threonine phosphatases in human development: Evidence from congenital disorders
Pieter Vaneynde, Iris Verbinnen, Veerle Janssens
Aging
|
November 11, 2023
PME-1-regulated neural cell death: new therapeutic opportunities?
Liesbeth Guffens, Rita Derua, Veerle Janssens
Trends in Biochemical Sciences
|
February 23, 2008
PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail)
Veerle Janssens, Sari Longin, Jozef Goris
Cell Death Discovery
|
July 27, 2023
PME-1 sensitizes glioblastoma cells to oxidative stress-induced cell death by attenuating PP2A-B55α-mediated inactivation of MAPKAPK2-RIPK1 signaling
Liesbeth Guffens, Rita Derua, Veerle Janssens
Page
of 8